When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ANGO - AngioDynamics on go with pilot study of NanoKnife in prostate cancer
AngioDynamics Inc.
The FDA has signed off on AngioDynamics' (ANGO-1%) application to launch a pilot study evaluating its NanoKnife Irreversible Electroporation for the ablation of prostate cancer tissue in low-risk patients.
More news on: AngioDynamics, Inc., Healthcare stocks news,